SCHEMBL978412

SCHEMBL978412

O=C(NO)c1sc(-c2ccc(OCCN3CCOCC3)cc2)nc1-c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55
CDC7 O00311 1/20 0.53
DBF4 Q9UBU7 1/20 0.53
ABL1 P00519 1/20 0.50
TUBB4A P04350 1/20 0.50
TUBB P07437 1/20 0.50
LYN P07948 1/20 0.50
TUBA3C P0DPH7 1/20 0.50
BCR P11274 1/20 0.50
SRC P12931 1/20 0.50
TUBA1B P68363 1/20 0.50
TUBA4A P68366 1/20 0.50
TUBB4B P68371 1/20 0.50
TUBB3 Q13509 1/20 0.50
TUBB2A Q13885 1/20 0.50
TUBB8 Q3ZCM7 1/20 0.50
TUBA3E Q6PEY2 1/20 0.50
TUBA1A Q71U36 1/20 0.50
TUBA1C Q9BQE3 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL976446 0.81 CDC7 (0.62) NPC1RAB9ACDC7DBF4GAA
SCHEMBL12336010 0.80 CD274 (0.60) SMN1; SMN2
SCHEMBL977661 0.76 CDC7 (0.70) NPC1RAB9ACDC7DBF4ALDH1A1
SCHEMBL975727 0.76 CDC7 (0.86) NPC1CDC7DBF4GAAHDAC1
SCHEMBL727659 0.76 TRPV4 (0.46) NPC1RAB9ASMN1; SMN2EPHX2KDM4E
SCHEMBL11898739 0.75 NPC1 (0.97) NPC1RAB9ALTA4HKDR
SCHEMBL14148655 0.74 ALDH1A1 (0.56) CDC7DBF4GAAALDH1A1
SCHEMBL31372426 0.73 EPHX2 (0.64) NPC1RAB9AEPHX2KDR
SCHEMBL21229068 0.72 SRC (0.56) NPC1RAB9AABL1TUBB4ATUBB
SCHEMBL978378 0.70 CDC7 (1.00) CDC7DBF4GAAHDAC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8673911-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2014-03-18 US disclosed
US-8673911-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2014-03-18 US disclosed
US-8673911-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2014-03-18 US disclosed
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2014-02-13 US disclosed
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2014-02-13 US disclosed
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2014-02-13 US disclosed
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2011-01-27 US disclosed
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2011-01-27 US disclosed
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC11, HDAC3 NPC1 1513/4885RAB9A 2879/4885CDC7 2481/4885
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC11, HDAC3 NPC1 1513/4885RAB9A 2879/4885CDC7 2481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.